ScholarIQanswers from OpenAlex

Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia

PaperCitations, authors & open-access status

Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia have?

ScholarIQcitation count

Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia has 8 citations in the OpenAlex counts ScholarIQ stores.

When was Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia published?

ScholarIQyear

Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia has 2021 year in the ScholarIQ index.

What is the open-access status of Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia?

ScholarIQoa status

Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia has closed oa status in the ScholarIQ index.

What is the DOI of Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia?

ScholarIQdoi

The DOI for Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia is on the source record.

What is the PMID of Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia?

ScholarIQpmid

The PMID for Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia is on the source record.

What is the OpenAlex record for Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia?

ScholarIQopenalex

The OpenAlex for Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial